2021 Report of the Incoming President

Posted by

Icon of scale representing regulatory news

Caroline D. Juran, BSPharm, DPh (Hon), presented the Report of the Incoming President during the 117th Annual Meeting: “Over the last year, I have found myself reflecting on NABP and its role in providing support to the boards of pharmacy. Our Association’s vision statement, “Innovating and collaborating today for a safer public health tomorrow,” seems especially […]

Read More ›

2021 Report of the Executive Director

Posted by

Icon of scale representing regulatory news

Lemrey “Al” Carter, PharmD, MS, RPh, presented the Report of the Executive Director during the 117th Annual Meeting: “Unfortunately, for a second year, I present to you virtually; I promise, I do exist! And I am very optimistic that in-person meetings are in our near future! As I look back on my official, yet unpredictable, […]

Read More ›

2021 Report of the Treasurer

Posted by

Icon of scale representing regulatory news

Reginald B. “Reggie” Dilliard, DPh, presented the Report of the Treasurer during the 117th Annual Meeting: “Good afternoon. I am so honored to have served as your treasurer this past year. And who knew what a year it would be? At this time last year, the pandemic had become increasingly worse, but at that point, the […]

Read More ›

2021 President’s Address

Posted by

Icon of scale representing regulatory news

Timothy D. Fensky, RPh, DPh, FACA, presented the President’s Address during the 117th Annual Meeting: “While it is unfortunate that I am addressing all of you from our computer monitors, in many ways, it feels extremely appropriate as I have spent the majority of my presidency behind this small camera lens. At last year’s meeting, I […]

Read More ›

2021 Report of the Executive Committee

Posted by

Icon of scale representing regulatory news

Jack W. “Jay” Campbell IV, JD, RPh, presented the Report of the Executive Committee during the 117th Annual Meeting: “Welcome to December 164th, 2020. Obviously, I am disappointed that I come to you remotely again this year. But I am pleased to see so many of you here today for what we all hope will […]

Read More ›

Recognition Resolution (Resolution 116-5-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-5-20 TITLE: Recognition Resolution ACTION: PASS WHEREAS, the individuals listed here have made significant contributions to NABP, the protection of the public health, and the practice of pharmacy: James A. “Buddy” Bowden (AR) Lois Cantin (MB) John T. Douglas (AR) Rocco F. Giruzzi, Jr (NY) William A. “Bill” Gouveia (MA) Leonard L. Inge, […]

Read More ›

Task Force on Medication Reuse (Resolution 116-4-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-4-20 TITLE: Task Force on Medication Reuse ACTION: PASS WHEREAS, every year millions of dollars of costly, previously dispensed, or short-dated medications may be thrown away while some uninsured or indigent patients fail to receive lifesaving therapies they need; and WHEREAS, the Model State Pharmacy Act and Model Rules of the National Association […]

Read More ›

Incorporating Criminal Background Checks into the NABP e-Profile System (Resolution 116-3-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-3-20 TITLE: Incorporating Criminal Background Checks into the NABP e-Profile System ACTION: PASS WHEREAS, the NABP Clearinghouse is a vital tool for member state boards of pharmacy to assess licensure or registration of applicants and to monitor professional accountability; and WHEREAS, some member state boards of pharmacy require a criminal background check as […]

Read More ›

Development and Administration of Patient-Specific Biologics (Resolution 116-2-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-2-20 TITLE: Development and Administration of Patient-Specific Biologics ACTION: PASS WHEREAS, drug manufacturers often receive blood components from a patient for the development of a patient-specific biologic and the final formulation is shipped directly to a practitioner for administration to the patient; and WHEREAS, it is unclear whether shipping of this patient-specific biologic […]

Read More ›

State Pharmacy Boards’ Responses to FDA Form 483 Observations (Resolution 116-1-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-1-20 TITLE: State Pharmacy Boards’ Responses to FDA Form 483 Observations ACTION: PASS WHEREAS, United States Food and Drug Administration (FDA) frequently conducts inspections of 503A pharmacies and can potentially issue an FDA Form 483, which documents the inspector’s observations and is not a citation or notice of violation of any law or […]

Read More ›
Page 5 of 25
1 3 4 5 6 7 25